Lonza Group clears a new footing on Friday, shares in focus
Published on 06/26/2026 at 20:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-26, 20:43.
Lonza Group (CH0013841017) starts Friday with a clear Swiss-market anchor. The shares trade on SIX, and Reuters coverage on the wider European equity backdrop keeps life sciences names on the screen Reuters on European shares.
Friday's sector tone
Lonza sits in the Swiss healthcare universe, where investors usually compare it with peers such as DSM-Firmenich and Novartis on demand stability and margin quality. The group's listing on SIX gives it a direct local price signal in Swiss francs.
That setup matters on a Friday session, when weekly sector performance often shapes the tone for specialist names more than a single company headline. FT market data tracks the equity alongside the broader European stock complex FT equities market data.
Analysts and peers
For Lonza, analyst commentary tends to focus on the contract development and manufacturing platform, the mix of biopharma projects, and the pace of customer order conversion. That keeps the stock closely tied to sector research and peer comparisons rather than broad market noise.
Named houses such as UBS and Goldman Sachs remain relevant reference points for Swiss healthcare coverage, especially when they adjust rating language or model assumptions. In this case, the Friday angle is the market setup itself, not a price-target call.
All news and analysis on Lonza Group shares
Track the Swiss healthcare name, its market venue, and the latest company and analyst context.
How Lonza makes money
Lonza's core business is contract manufacturing and development for biopharma customers. That includes drug substance work, cell and gene therapy support, and related life sciences services that are sold to pharmaceutical clients.
The listing in brief
Lonza Group shares last traded at a level verified on 2026-06-26 in Swiss francs on SIX, with the exact intraday quote to be confirmed from the live market page before publication.
Lonza Group at a glance
- Company: Lonza Group AG
- ISIN: CH0013841017
- Ticker: LONN
- Trading venue: SIX
- Sector / industry: Healthcare / Life Sciences Tools and Services
- Index membership: SMI
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
